About Global Health Limited
Data last updated: 22 December 2025
Global Health Limited is a public limited company based in New Delhi, Delhi, India. It specialises in hospital and clinical services, a part of the broader healthcare sector. Incorporated on 13 August 2004, the company has been in operation for over 22 years.
Registered with ROC Delhi under CIN L85110DL2004PLC128319. Listed on BSE: 543654.
Capital: an authorised share capital of ₹233.52 Cr and a paid-up capital of ₹53.76 Cr. Formerly known as Global Health Private Limited. It is led by directors including Praveen Mahajan and Rahul Ranjan.
Last AGM: 19 September 2024. Financial statements filed for year ended 31 March 2024. Office: Medanta – Mediclinic E – 18 Defence Colony, New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2025, the company reported a revenue of ₹3,771.41 Cr, a growth of 13% compared to the previous year.
The company has a workforce of approximately 6,028 employees as per the latest available data. Its group structure includes 3 subsidiaries.
The company is associated with 6 brands, including Lifecard, Hothealth, Primaryclinic, Referralnet, Global Health among others. As per MCA filings, the company has open charges of ₹890 Cr and satisfied charges of ₹996.42 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medanta.org.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressMedanta – Mediclinic E – 18 Defence Colony, New Delhi, Delhi, India – 110024
-
IndustryHealthcare, Hospitals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Global Health Limited
Global Health Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85110DL2004PLC128319, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85110DL2004PLC128319 | Current |
| U85110DL2004PLC128319 | Previous |
| U85110DL2004PTC128319 | Previous |
Associated Brands with Global Health Limited
Global Health Limited operates multiple associated brands including Lifecard, HotHealth, and PrimaryClinic. These brands represent Global Health Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| App for managing personal health records and tracking medical progress. | lifecard.com | |
| Offers digital platform for healthcare with online bookings, telehealth, and patient forms. | hothealth.com | |
| Medical software for efficient practice management and patient care. | primaryclinic.com.au | |
| Secure platform for exchanging patient information among healthcare providers. | referralnet.com.au | |
| Software applications for Australia's healthcare sector are developed. | global-health.com | |
| Chain of multi-super specialty healthcare hospitals | medanta.org |
Competitors & Alternatives of Global Health Limited
Brands and companies operating in the same space as Global Health Limited include Modernizing Medicine, KIMS Hospitals, Eka Care and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
AI-driven EMR and practice management software is delivered for clinics. | Boca Raton, United States, United States | 2010 |
|
|
Multispeciality secondary and tertiary care is provided by hospital chains. | Secunderabad, India, India | 1999 |
|
|
AI-powered EMR, EHR, and patient engagement solutions are provided. | Bengaluru, India, India | 2020 |
|
|
Cloud-based oncology management tools are provided for cancer care providers. | New York, United States, United States | 2012 |
|
|
Cloud-based EHR system is provided for physicians' practices. | San Francisco, United States, United States | 2005 |
|
|
Multi-specialty hospital services are provided across India by Fortis Healthcare. | Gurugram, India, India | 1996 |
|
|
A chain of multi-specialty hospitals is operated in India. | Delhi, India, India | 2011 |
|
|
A practice management platform is provided for nutrition professionals. | New York, United States, United States | 2014 |
|
|
Chain of multi-speciality hospitals | Chennai, India, India | 1999 |
|
|
Chain of multispecialty hospitals | Chennai, India, India | 1983 |
Business Activity of Global Health Limited
Global Health Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | ********* |
Auditor Details of Global Health Limited
Global Health Limited is audited by Walker Chandiok & Co LLP (ICAI peer reviewed, certificate valid till 2028-05-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Walker Chandiok & Co LLP (ICAI peer reviewed, certificate valid till 2028-05-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Global Health Limited
Global Health Limited is currently managed by 14 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Mahajan | Director | 29 Oct 2020 | 5 Years 8 Months | Current |
| Rahul Ranjan | Company Secretary | 08 Jul 2021 | 5 Years 0 Months | Current |
| Hari Shanker Bhartia | Director | 31 Jul 2021 | 4 Years 11 Months | Current |
| Rajan Bharti Mittal | Director | 28 Jul 2021 | 4 Years 11 Months | Current |
|
Yogesh Kumar Gupta
Also directs:
Global Health Limited, Ghl Pharma & Diagnostic Private Limited
|
Cfo | 08 Feb 2024 | 2 Years 5 Months | Current |
|
Ravi Gupta
Also directs:
Devyani International Limited, Varun Beverages Limited, Global Health Limited and 5 more
|
Director | 28 Jul 2021 | 4 Years 11 Months | Current |
Financials of Global Health Limited FY 2026 filings available
Global Health Limited reported revenue of ₹4,410.27 Cr (up 19.44% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹4,410.27 Cr | ₹3,692.32 Cr | ₹3,275.11 Cr | ₹2,694.25 Cr |
| Other Income | ₹98.59 Cr | ₹79.1 Cr | ₹74.66 Cr | ₹64.91 Cr |
| Total Income | ₹4,508.86 Cr | ₹3,771.41 Cr | ₹3,349.78 Cr | ₹2,759.16 Cr |
| Cost of Materials Consumed | ₹882.13 Cr | ₹789.96 Cr | ₹687.69 Cr | ₹571.12 Cr |
| Purchases of Stock-in-Trade | ₹117.3 Cr | ₹92.46 Cr | ₹73.97 Cr | ₹55.74 Cr |
| Changes in Inventories | -₹2.63 Cr | -₹2.75 Cr | -₹2.29 Cr | -₹1.58 Cr |
| Employee Benefit Expense | ₹1,096.11 Cr | ₹824.54 Cr | ₹734.86 Cr | ₹634.35 Cr |
| Finance Costs | ₹79.11 Cr | ₹65.26 Cr | ₹73.91 Cr | ₹77.92 Cr |
| Depreciation & Amortisation | ₹222.54 Cr | ₹193.75 Cr | ₹172.73 Cr | ₹149.91 Cr |
| Other Expenses | ₹1,398.26 Cr | ₹1,111.04 Cr | ₹981.82 Cr | ₹822.41 Cr |
| Total Expenses | ₹3,792.82 Cr | ₹3,074.26 Cr | ₹2,722.68 Cr | ₹2,309.87 Cr |
| Profit Before Exceptional Items & Tax | ₹716.04 Cr | ₹697.15 Cr | ₹627.1 Cr | ₹449.29 Cr |
| Exceptional Items | -₹1.02 Cr | -₹49.9 Cr | ₹0 | ₹0 |
| Profit Before Tax | ₹715.02 Cr | ₹647.26 Cr | ₹627.1 Cr | ₹449.29 Cr |
| Total Tax Expense | ₹160.95 Cr | ₹165.94 Cr | ₹149.04 Cr | ₹123.21 Cr |
| Net Profit | ₹554.07 Cr | ₹481.32 Cr | ₹478.06 Cr | ₹326.08 Cr |
| attributable to Owners | ₹556.46 Cr | ₹481.44 Cr | ₹478.19 Cr | - |
| attributable to NCI | -₹2.39 Cr | -₹11.9 Lakh | -₹13.4 Lakh | - |
| Other Comprehensive Income | ₹3.65 Cr | -₹67 Lakh | -₹93.8 Lakh | ₹1.42 Cr |
| Total Comprehensive Income | ₹557.71 Cr | ₹480.65 Cr | ₹477.12 Cr | ₹327.5 Cr |
| EBITDA (computed) | ₹1,017.69 Cr | ₹956.16 Cr | ₹873.74 Cr | ₹677.12 Cr |
| Basic EPS | ₹20.71 | ₹17.92 | ₹17.80 | ₹12.58 |
| Diluted EPS | ₹20.66 | ₹17.92 | ₹17.80 | ₹12.57 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹5,905 Cr | ₹4,766.23 Cr | ₹4,304.08 Cr | ₹4,115.96 Cr |
| Non-current Assets | ₹4,230.08 Cr | ₹3,233.11 Cr | ₹2,795.35 Cr | ₹2,536.48 Cr |
| Current Assets | ₹1,674.92 Cr | ₹1,533.12 Cr | ₹1,508.73 Cr | ₹1,579.49 Cr |
| Property, Plant & Equipment | ₹3,778.71 Cr | ₹1,975.26 Cr | ₹1,812.93 Cr | ₹1,707.84 Cr |
| Inventories | ₹78.98 Cr | ₹67.14 Cr | ₹66.85 Cr | ₹60.37 Cr |
| Trade Receivables | ₹411.19 Cr | ₹291.86 Cr | ₹215.31 Cr | ₹194.2 Cr |
| Cash & Equivalents | ₹127.33 Cr | ₹230.2 Cr | ₹424.61 Cr | ₹767.24 Cr |
| Equity (Net Worth) | ₹3,984.28 Cr | ₹3,387.51 Cr | ₹2,905.59 Cr | ₹2,428.21 Cr |
| Equity Share Capital | ₹53.74 Cr | ₹53.72 Cr | ₹53.7 Cr | ₹53.64 Cr |
| Borrowings (Non-current) | ₹1,127.06 Cr | ₹264.1 Cr | ₹283.47 Cr | ₹737.12 Cr |
| Borrowings (Current) | ₹62.99 Cr | ₹63.78 Cr | ₹135.87 Cr | ₹105.1 Cr |
| Total Debt (computed) | ₹1,190.05 Cr | ₹327.88 Cr | ₹419.34 Cr | ₹842.22 Cr |
| Current Liabilities | ₹627.13 Cr | ₹618.82 Cr | ₹617.73 Cr | ₹572.55 Cr |
| Total Liabilities | ₹1,920.73 Cr | ₹1,378.72 Cr | ₹1,398.48 Cr | ₹1,687.76 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹714.39 Cr | ₹623.76 Cr | ₹612.09 Cr | ₹644.52 Cr |
| Investing Cash Flow | -₹1,065.11 Cr | -₹720.94 Cr | -₹440.8 Cr | -₹342.34 Cr |
| Financing Cash Flow | ₹247.85 Cr | -₹97.23 Cr | -₹513.92 Cr | ₹345.64 Cr |
| Capital Expenditure | ₹838.19 Cr | ₹516.55 Cr | ₹278.59 Cr | ₹235.99 Cr |
| Free Cash Flow (computed) | -₹123.8 Cr | ₹107.21 Cr | ₹333.5 Cr | ₹408.53 Cr |
| Dividends Paid | ₹13.44 Cr | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹102.87 Cr | -₹194.41 Cr | -₹342.64 Cr | ₹647.81 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,159.05 Cr | ₹1,121.05 Cr | ₹1,099.22 Cr | ₹1,030.84 Cr | ₹931.25 Cr | ₹943.44 Cr | ₹956.56 Cr | ₹861.08 Cr | ₹808.63 Cr | ₹832.6 Cr | ₹843.94 Cr | ₹773.04 Cr |
| Other Income | ₹36.74 Cr | ₹21.78 Cr | ₹19.73 Cr | ₹20.46 Cr | ₹22.93 Cr | ₹16.02 Cr | ₹18.22 Cr | ₹21.93 Cr | ₹27.42 Cr | ₹21.93 Cr | ₹20.75 Cr | ₹21.46 Cr |
| Total Income | ₹1,195.79 Cr | ₹1,142.83 Cr | ₹1,118.95 Cr | ₹1,051.29 Cr | ₹954.18 Cr | ₹959.46 Cr | ₹974.77 Cr | ₹883 Cr | ₹836.05 Cr | ₹854.53 Cr | ₹864.69 Cr | ₹794.5 Cr |
| Cost of Materials Consumed | ₹215.65 Cr | ₹226.72 Cr | ₹226.69 Cr | ₹213.08 Cr | ₹191.48 Cr | ₹206.6 Cr | ₹204.28 Cr | ₹187.61 Cr | ₹176.52 Cr | ₹172.24 Cr | ₹174.41 Cr | ₹164.52 Cr |
| Purchases of Stock-in-Trade | ₹27.8 Cr | ₹28.93 Cr | ₹28.78 Cr | ₹31.79 Cr | ₹20.51 Cr | ₹20.7 Cr | ₹28.15 Cr | ₹23.1 Cr | ₹17.57 Cr | ₹18.13 Cr | ₹19.97 Cr | ₹18.3 Cr |
| Changes in Inventories | ₹3.08 Cr | ₹1.6 Lakh | ₹8 Lakh | -₹5.81 Cr | ₹1.63 Cr | ₹1.9 Cr | -₹4.45 Cr | -₹1.84 Cr | -₹34.1 Lakh | ₹29.64 Lakh | -₹80.53 Lakh | -₹1.44 Cr |
| Employee Benefit Expense | ₹284.7 Cr | ₹280.67 Cr | ₹274.33 Cr | ₹256.4 Cr | ₹204.05 Cr | ₹205.02 Cr | ₹214.29 Cr | ₹201.19 Cr | ₹187.8 Cr | ₹184.86 Cr | ₹183.79 Cr | ₹177.92 Cr |
| Finance Costs | ₹26.71 Cr | ₹21.51 Cr | ₹17.11 Cr | ₹13.79 Cr | ₹15.03 Cr | ₹16.28 Cr | ₹15.98 Cr | ₹17.98 Cr | ₹18.23 Cr | ₹17.68 Cr | ₹20.09 Cr | ₹17.92 Cr |
| Depreciation & Amortisation | ₹66.52 Cr | ₹61.19 Cr | ₹49.73 Cr | ₹45.11 Cr | ₹49.25 Cr | ₹48.45 Cr | ₹49.43 Cr | ₹46.62 Cr | ₹45.45 Cr | ₹43.98 Cr | ₹42.91 Cr | ₹40.38 Cr |
| Other Expenses | ₹384.06 Cr | ₹367.42 Cr | ₹338.39 Cr | ₹308.39 Cr | ₹288.89 Cr | ₹271.45 Cr | ₹286 Cr | ₹264.71 Cr | ₹247.74 Cr | ₹244.98 Cr | ₹253.72 Cr | ₹235.86 Cr |
| Total Expenses | ₹1,008.51 Cr | ₹986.45 Cr | ₹935.12 Cr | ₹862.75 Cr | ₹770.84 Cr | ₹770.39 Cr | ₹793.67 Cr | ₹739.35 Cr | ₹692.97 Cr | ₹682.17 Cr | ₹694.09 Cr | ₹653.46 Cr |
| Profit Before Exceptional Items & Tax | ₹187.28 Cr | ₹156.38 Cr | ₹183.83 Cr | ₹188.55 Cr | ₹183.33 Cr | ₹189.07 Cr | ₹181.1 Cr | ₹143.65 Cr | ₹143.09 Cr | ₹172.36 Cr | ₹170.6 Cr | ₹141.04 Cr |
| Exceptional Items | ₹0 | -₹36.6 Cr | ₹15.99 Cr | ₹19.59 Cr | -₹49.9 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹187.28 Cr | ₹119.78 Cr | ₹199.81 Cr | ₹208.14 Cr | ₹133.44 Cr | ₹189.07 Cr | ₹181.1 Cr | ₹143.65 Cr | ₹143.09 Cr | ₹172.36 Cr | ₹170.6 Cr | ₹141.04 Cr |
| Total Tax Expense | ₹45.63 Cr | ₹24.75 Cr | ₹41.41 Cr | ₹49.16 Cr | ₹32.06 Cr | ₹46.21 Cr | ₹50.28 Cr | ₹37.39 Cr | ₹15.74 Cr | ₹48.82 Cr | ₹45.44 Cr | ₹39.03 Cr |
| Net Profit | ₹141.65 Cr | ₹95.03 Cr | ₹158.4 Cr | ₹158.98 Cr | ₹101.38 Cr | ₹142.86 Cr | ₹130.82 Cr | ₹106.26 Cr | ₹127.35 Cr | ₹123.54 Cr | ₹125.16 Cr | ₹102.01 Cr |
| attributable to Owners | ₹143.99 Cr | ₹95.02 Cr | ₹158.44 Cr | ₹159.01 Cr | ₹101.4 Cr | ₹142.91 Cr | - | ₹106.29 Cr | ₹127.38 Cr | ₹123.64 Cr | - | ₹0 |
| attributable to NCI | -₹2.34 Cr | ₹1.1 Lakh | -₹4.1 Lakh | -₹2.7 Lakh | -₹2.2 Lakh | -₹4.9 Lakh | - | -₹2.2 Lakh | -₹3.4 Lakh | -₹10 Lakh | - | ₹0 |
| Other Comprehensive Income | ₹3.72 Cr | ₹62 Lakh | -₹92.3 Lakh | ₹23.3 Lakh | -₹2.27 Cr | ₹2.88 Cr | ₹74.8 Lakh | -₹2.03 Cr | -₹90,000 | ₹52 Lakh | ₹95.88 Lakh | -₹2.41 Cr |
| Total Comprehensive Income | ₹145.37 Cr | ₹95.65 Cr | ₹157.48 Cr | ₹159.22 Cr | ₹99.1 Cr | ₹145.74 Cr | ₹131.57 Cr | ₹104.24 Cr | ₹127.34 Cr | ₹124.06 Cr | ₹126.12 Cr | ₹99.6 Cr |
| EBITDA (computed) | ₹280.51 Cr | ₹239.08 Cr | ₹250.67 Cr | ₹247.44 Cr | ₹247.62 Cr | ₹253.79 Cr | ₹246.5 Cr | ₹208.25 Cr | ₹206.77 Cr | ₹234.03 Cr | ₹233.6 Cr | ₹199.34 Cr |
| Basic EPS | ₹5.36 | ₹3.54 | ₹5.89 | ₹5.92 | ₹3.77 | ₹5.32 | ₹4.87 | ₹3.96 | ₹4.74 | ₹4.61 | ₹4.66 | ₹3.80 |
| Diluted EPS | ₹5.34 | ₹3.54 | ₹5.89 | ₹5.91 | ₹3.77 | ₹5.32 | ₹4.87 | ₹3.96 | ₹4.74 | ₹4.60 | ₹4.66 | ₹3.80 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹3,709.38 Cr | ₹3,204.15 Cr | ₹2,280.01 Cr | ₹1,959.45 Cr |
| Other Income | ₹106.41 Cr | ₹90.93 Cr | ₹102.87 Cr | ₹61.68 Cr |
| Total Income | ₹3,815.79 Cr | ₹3,295.08 Cr | ₹2,382.88 Cr | ₹2,021.13 Cr |
| Cost of Materials Consumed | ₹785.86 Cr | ₹715.81 Cr | ₹506.15 Cr | ₹430.1 Cr |
| Purchases of Stock-in-Trade | ₹1.94 Cr | ₹40.39 Cr | ₹42.34 Cr | ₹35.9 Cr |
| Changes in Inventories | ₹4.61 Cr | ₹2.62 Cr | -₹62.5 Lakh | -₹40.65 Lakh |
| Employee Benefit Expense | ₹989.26 Cr | ₹746.29 Cr | ₹591.06 Cr | ₹531.63 Cr |
| Finance Costs | ₹41.09 Cr | ₹33.39 Cr | ₹24.46 Cr | ₹26.16 Cr |
| Depreciation & Amortisation | ₹170.91 Cr | ₹149.61 Cr | ₹87.09 Cr | ₹86.09 Cr |
| Other Expenses | ₹1,172.85 Cr | ₹934.01 Cr | ₹643.74 Cr | ₹559.94 Cr |
| Total Expenses | ₹3,166.51 Cr | ₹2,622.13 Cr | ₹1,894.21 Cr | ₹1,669.42 Cr |
| Profit Before Exceptional Items & Tax | ₹649.28 Cr | ₹672.94 Cr | ₹488.67 Cr | ₹351.71 Cr |
| Exceptional Items | ₹37.7 Lakh | -₹49.9 Cr | ₹0 | ₹0 |
| Profit Before Tax | ₹649.65 Cr | ₹623.05 Cr | ₹488.67 Cr | ₹351.71 Cr |
| Total Tax Expense | ₹153.45 Cr | ₹161.52 Cr | ₹127.78 Cr | ₹88.46 Cr |
| Net Profit | ₹496.2 Cr | ₹461.53 Cr | ₹360.89 Cr | ₹263.25 Cr |
| Other Comprehensive Income | ₹3.33 Cr | -₹96.8 Lakh | -₹1.12 Cr | ₹1.16 Cr |
| Total Comprehensive Income | ₹499.53 Cr | ₹460.56 Cr | ₹359.78 Cr | ₹264.4 Cr |
| EBITDA (computed) | ₹861.27 Cr | ₹855.95 Cr | ₹600.22 Cr | ₹463.96 Cr |
| Basic EPS | ₹18.46 | ₹17.18 | ₹13.44 | ₹10.16 |
| Diluted EPS | ₹18.42 | ₹17.18 | ₹13.44 | ₹10.15 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹5,351.47 Cr | ₹4,440.59 Cr | ₹3,523.38 Cr | ₹3,178.7 Cr |
| Non-current Assets | ₹3,781.13 Cr | ₹2,987.83 Cr | ₹2,232.83 Cr | ₹1,780.79 Cr |
| Current Assets | ₹1,570.34 Cr | ₹1,452.75 Cr | ₹1,290.55 Cr | ₹1,397.92 Cr |
| Property, Plant & Equipment | ₹2,889.36 Cr | ₹1,466.3 Cr | ₹563.91 Cr | ₹543.21 Cr |
| Inventories | ₹50.9 Cr | ₹49 Cr | ₹44.27 Cr | ₹42.21 Cr |
| Trade Receivables | ₹386.85 Cr | ₹291.59 Cr | ₹191.87 Cr | ₹173.1 Cr |
| Cash & Equivalents | ₹95.91 Cr | ₹190.07 Cr | ₹218.67 Cr | ₹642.78 Cr |
| Equity (Net Worth) | ₹4,012.57 Cr | ₹3,497.61 Cr | ₹2,848.8 Cr | ₹2,488.86 Cr |
| Equity Share Capital | ₹53.74 Cr | ₹53.72 Cr | ₹53.7 Cr | ₹53.64 Cr |
| Borrowings (Non-current) | ₹654.07 Cr | ₹114.31 Cr | ₹176.82 Cr | ₹57.98 Cr |
| Borrowings (Current) | ₹28.6 Cr | ₹26.13 Cr | ₹59.18 Cr | ₹43.56 Cr |
| Total Debt (computed) | ₹682.66 Cr | ₹140.44 Cr | ₹236.01 Cr | ₹101.55 Cr |
| Current Liabilities | ₹531.11 Cr | ₹518.83 Cr | ₹419.59 Cr | ₹396.65 Cr |
| Total Liabilities | ₹1,338.9 Cr | ₹942.98 Cr | ₹674.58 Cr | ₹689.84 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹573.32 Cr | ₹527.67 Cr | ₹340.64 Cr | ₹430.53 Cr |
| Investing Cash Flow | -₹931.35 Cr | -₹638.2 Cr | -₹698.52 Cr | -₹257.29 Cr |
| Financing Cash Flow | ₹263.88 Cr | -₹94.49 Cr | -₹66.23 Cr | ₹404.22 Cr |
| Capital Expenditure | ₹675.56 Cr | ₹427.69 Cr | ₹186.33 Cr | ₹116.01 Cr |
| Free Cash Flow (computed) | -₹102.24 Cr | ₹99.98 Cr | ₹154.31 Cr | ₹314.52 Cr |
| Dividends Paid | ₹13.44 Cr | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹94.16 Cr | -₹205.03 Cr | -₹424.11 Cr | ₹577.47 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹960.63 Cr | ₹940.17 Cr | ₹926.43 Cr | ₹882.16 Cr | ₹802.87 Cr | ₹624.4 Cr | ₹664.61 Cr | ₹611.45 Cr | ₹578.65 Cr | ₹561.68 Cr | ₹580.15 Cr | ₹544.59 Cr |
| Other Income | ₹35.81 Cr | ₹24.66 Cr | ₹22.8 Cr | ₹23.14 Cr | ₹25.67 Cr | ₹22.17 Cr | ₹23.58 Cr | ₹26.7 Cr | ₹32.55 Cr | ₹25.83 Cr | ₹26.24 Cr | ₹33.2 Cr |
| Total Income | ₹996.43 Cr | ₹964.83 Cr | ₹949.23 Cr | ₹905.3 Cr | ₹828.53 Cr | ₹646.57 Cr | ₹688.19 Cr | ₹638.15 Cr | ₹611.19 Cr | ₹587.51 Cr | ₹606.38 Cr | ₹577.79 Cr |
| Cost of Materials Consumed | ₹188.64 Cr | ₹201.83 Cr | ₹203.22 Cr | ₹192.16 Cr | ₹172.38 Cr | ₹148.92 Cr | ₹152.11 Cr | ₹140.56 Cr | ₹133.8 Cr | ₹125.45 Cr | ₹126.57 Cr | ₹120.33 Cr |
| Purchases of Stock-in-Trade | -₹50,000 | -₹56.7 Lakh | -₹4.4 Lakh | ₹2.56 Cr | ₹5.82 Cr | ₹11.09 Cr | ₹11.78 Cr | ₹11.69 Cr | ₹9.95 Cr | ₹10.11 Cr | ₹11.13 Cr | ₹11.15 Cr |
| Changes in Inventories | ₹0 | ₹59.8 Lakh | ₹5.2 Lakh | ₹3.96 Cr | ₹3.21 Cr | -₹27.4 Lakh | ₹21.5 Lakh | -₹52.4 Lakh | -₹16 Lakh | ₹51.84 Lakh | ₹3.67 Lakh | -₹1.02 Cr |
| Employee Benefit Expense | ₹255.68 Cr | ₹252.3 Cr | ₹248.33 Cr | ₹232.95 Cr | ₹185.42 Cr | ₹158.23 Cr | ₹168.1 Cr | ₹157.5 Cr | ₹149.17 Cr | ₹147.12 Cr | ₹148.58 Cr | ₹145.72 Cr |
| Finance Costs | ₹13.46 Cr | ₹13.08 Cr | ₹8.88 Cr | ₹5.66 Cr | ₹7.1 Cr | ₹5.94 Cr | ₹5.37 Cr | ₹5.95 Cr | ₹6.21 Cr | ₹5.76 Cr | ₹6.11 Cr | ₹6.38 Cr |
| Depreciation & Amortisation | ₹52.21 Cr | ₹47.86 Cr | ₹37.43 Cr | ₹33.41 Cr | ₹37.98 Cr | ₹23.44 Cr | ₹24.91 Cr | ₹23.3 Cr | ₹23.39 Cr | ₹21.73 Cr | ₹21.54 Cr | ₹20.43 Cr |
| Other Expenses | ₹322.97 Cr | ₹311.64 Cr | ₹282.3 Cr | ₹255.95 Cr | ₹240.85 Cr | ₹166.91 Cr | ₹182.09 Cr | ₹169.92 Cr | ₹163.67 Cr | ₹155.96 Cr | ₹165.52 Cr | ₹159.06 Cr |
| Total Expenses | ₹832.96 Cr | ₹826.74 Cr | ₹780.17 Cr | ₹726.64 Cr | ₹652.75 Cr | ₹514.26 Cr | ₹544.58 Cr | ₹508.4 Cr | ₹486.03 Cr | ₹466.64 Cr | ₹479.49 Cr | ₹462.05 Cr |
| Profit Before Exceptional Items & Tax | ₹163.48 Cr | ₹138.09 Cr | ₹169.06 Cr | ₹178.65 Cr | ₹175.78 Cr | ₹132.31 Cr | ₹143.61 Cr | ₹129.74 Cr | ₹125.17 Cr | ₹120.87 Cr | ₹126.89 Cr | ₹115.74 Cr |
| Exceptional Items | ₹0 | -₹35.2 Cr | ₹15.99 Cr | ₹19.59 Cr | -₹49.9 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹163.48 Cr | ₹102.89 Cr | ₹185.05 Cr | ₹198.25 Cr | ₹125.89 Cr | ₹132.31 Cr | ₹143.61 Cr | ₹129.74 Cr | ₹125.17 Cr | ₹120.87 Cr | ₹126.89 Cr | ₹115.74 Cr |
| Total Tax Expense | ₹39.34 Cr | ₹22.98 Cr | ₹44.85 Cr | ₹46.28 Cr | ₹32.48 Cr | ₹33.01 Cr | ₹39.14 Cr | ₹33.46 Cr | ₹32.93 Cr | ₹33.53 Cr | ₹31.8 Cr | ₹29.53 Cr |
| Net Profit | ₹124.13 Cr | ₹79.91 Cr | ₹140.2 Cr | ₹151.96 Cr | ₹93.41 Cr | ₹99.31 Cr | ₹104.47 Cr | ₹96.28 Cr | ₹92.24 Cr | ₹87.34 Cr | ₹95.1 Cr | ₹86.21 Cr |
| Other Comprehensive Income | ₹3.43 Cr | ₹47.6 Lakh | -₹79.8 Lakh | ₹22.5 Lakh | -₹2.26 Cr | ₹2.68 Cr | ₹71.1 Lakh | -₹1.9 Cr | -₹6.7 Lakh | ₹42.77 Lakh | ₹66.17 Lakh | -₹2.14 Cr |
| Total Comprehensive Income | ₹127.56 Cr | ₹80.38 Cr | ₹139.4 Cr | ₹152.19 Cr | ₹91.15 Cr | ₹101.99 Cr | ₹105.18 Cr | ₹94.39 Cr | ₹92.17 Cr | ₹87.77 Cr | ₹95.76 Cr | ₹84.07 Cr |
| EBITDA (computed) | ₹229.15 Cr | ₹199.03 Cr | ₹215.37 Cr | ₹217.72 Cr | ₹220.86 Cr | ₹161.69 Cr | ₹173.89 Cr | ₹159 Cr | ₹154.77 Cr | ₹148.36 Cr | ₹154.54 Cr | ₹142.55 Cr |
| Basic EPS | ₹4.62 | ₹2.97 | ₹5.22 | ₹5.66 | ₹3.48 | ₹3.70 | ₹3.89 | ₹3.58 | ₹3.43 | ₹3.25 | ₹3.54 | ₹3.21 |
| Diluted EPS | ₹4.61 | ₹2.97 | ₹5.22 | ₹5.65 | ₹3.48 | ₹3.70 | ₹3.89 | ₹3.58 | ₹3.43 | ₹3.25 | ₹3.54 | ₹3.21 |
Shareholding Pattern of Global Health Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 33.01%, foreign institutional investors hold 10.15%, domestic institutional investors hold 14.76%, retail and other public shareholders hold 42.00% of Global Health Limited. The company had 147,390 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 33.01% | 33.01% | 33.01% | 33.01% | 33.03% | 33.03% |
| Public | 66.92% | 66.93% | 66.93% | 66.93% | 66.97% | 66.97% |
| Employee Trusts | 0.08% | 0.06% | 0.06% | 0.06% | 0.00% | 0.00% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Promoters | 33.01% | 33.03% | 33.04% | 33.08% |
| Public | 66.92% | 66.97% | 66.96% | 66.92% |
| Employee Trusts | 0.08% | 0.00% | 0.00% | 0.00% |
| Promoter change (YoY, %pts) | -0.02 | -0.01 | -0.04 | - |
Board & Governance of Global Health Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Global Health Limited has 10 directors - 5 independent and 2 executive. The board is chaired by Naresh Trehan.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Naresh Trehan | Executive Director · MD · Chairperson | 2004-08-13 | 2 |
| Pankaj Prakash Sahni | Executive Director · CEO | 2023-01-01 | 1 |
| Hari Shanker Bhartia | Non-Executive - Independent Director | 2021-03-23 | 6 |
| Praveen Mahajan | Non-Executive - Independent Director | 2020-07-10 | 2 |
| Rajan Bharti Mittal | Non-Executive - Independent Director | 2021-07-08 | 5 |
| Ravi Gupta | Non-Executive - Independent Director | 2021-07-08 | 4 |
| Ravi Kant Jaipuria | Non-Executive - Nominee Director | 2015-10-06 | 3 |
| Shonan Purie Trehan | Non-Executive - Non Independent Director | 2026-03-13 | 1 |
| Sunil Sachdeva | Non-Executive - Non Independent Director | 2004-08-13 | 1 |
| Vikram Singh Mehta | Non-Executive - Independent Director | 2021-01-25 | 3 |
| Committee | Members |
|---|---|
| Audit Committee | Ravi Gupta (Chairperson), Praveen Mahajan, Vikram Singh Mehta |
| Nomination and remuneration committee | Vikram Singh Mehta (Chairperson), Praveen Mahajan, Rajan Bharti Mittal, Naresh Trehan |
| Stakeholders Relationship Committee | Ravi Gupta (Chairperson), Ravi Kant Jaipuria, Rajan Bharti Mittal, Hari Shanker Bhartia |
| Risk Management Committee | Ravi Gupta (Chairperson), Praveen Mahajan, Pankaj Prakash Sahni |
| Corporate Social Responsibility Committee | Naresh Trehan (Chairperson), Sunil Sachdeva, Rajan Bharti Mittal, Vikram Singh Mehta |
Group Structure of Global Health Limited
Global Health Limited has 3 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Global Health Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Medanta Holdings Private Limited | U74140DL2013PTC250579 | - |
| Global Health Patliputra Private Limited | U74999DL2015PTC283932 | - |
| Ghl Pharma & Diagnostic Private Limited | U85110DL2022PTC400942 | - |
Showing major subsidiaries. Total: 3.
Charges & Borrowings of Global Health Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Nov 2025 | Hdfc Bank Limited | ₹100 Cr | Open |
| 29 Jul 2025 | Sbicap Trustee Company Limited | ₹50 Cr | Open |
| 27 Mar 2025 | Others | ₹100 Cr | Open |
| 25 Sep 2024 | Sbicap Trustee Company Limited | ₹400 Cr | Open |
| 02 Aug 2021 | Yes Bank Limited | ₹140 Cr | Open |
Total charge records: 14 View all charges
Employees and EPFO Compliance at Global Health Limited
Global Health Limited has a workforce of 6,028 employees as of Apr 08, 2024.
Employee Count & EPFO Data of Global Health Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Global Health Limited
GSTIN & GST Filing Data of Global Health Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Global Health Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Global Health Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Global Health Limited
MSME Payment Delays by Global Health Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Global Health Limited
Subsidiaries & Group Companies of Global Health Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Global Health Limited with ownership details.
MCA Filings & Documents of Global Health Limited
MCA Filings & Documents of Global Health Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Global Health Limited
Recent News on Global Health Limited
Frequently Asked Questions about Global Health Limited
Global Health Limited is an active public limited company in the healthcare sector based in New Delhi, Delhi, India. It was incorporated on 13 August 2004 (22+ years old) and is registered under CIN L85110DL2004PLC128319. Listed on BSE: 543654. The company has 6,028 employees.
Global Health Limited reported revenue of ₹3,771.41 Cr for FY 2025 (up 13.00% YoY).
The current directors of Global Health Limited are:
- Praveen Mahajan
- Rahul Ranjan
- Hari Shanker Bhartia
- Rajan Bharti Mittal
- Yogesh Kumar Gupta
- Pankaj Prakash Sahni
- Ravi Gupta
- Ravi Kant Jaipuria
- Vikram Singh Mehta
- Rahul Rahul
- Naresh Trehan
- Sunil Sachdeva
- Pankaj Sahni
- Yogesh Kumar Gupta
The primary industry of Global Health Limited is healthcare. The company specifically operates in hospitals. The company is currently active in this sector.
Yes. Global Health Limited is listed on BSE with code 543654.
Global Health Limited can be reached at the registered office: Medanta – Mediclinic E – 18 Defence Colony, New Delhi, Delhi, India – 110024, or through the website medanta.org.